Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine for treating digestive tract inflammation

A digestive tract and drug technology, applied in the field of medicine, can solve problems such as stomach injury and liver injury, and achieve the effect of reducing burden, low price and remarkable effect

Inactive Publication Date: 2016-11-09
胡淑贤
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the application of drugs for protecting gastric mucosa, sulfur powder aluminum, bismuth, glyceplatin and antibiotic drugs, for spirochetes exceeding the standard, most of them are treated with norfloxacin, but all antibiotics cause great damage to the stomach itself, and at the same time It can also cause great damage to the liver and kidneys
The result is often more harm than good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating digestive tract inflammation
  • Medicine for treating digestive tract inflammation
  • Medicine for treating digestive tract inflammation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Basic fuchsin toxicity test:

[0049] Materials: A total of 24 white guinea pigs were purchased from Shenyang Pharmaceutical University and raised routinely;

[0050] Basic fuchsin was purchased from Tianjin Juhua Chemical Co., Ltd.

[0051] Ratio and grouping of experimental animals: the experimental guinea pigs were randomly divided into 4 groups (6 in each group, half male and half male), respectively blank control group, basic fuchsin high, medium and low dose groups.

[0052] Dosing method: each guinea pig was administered once a day at a fixed time in the morning. kg body weight / d; the administration time was 21 days, and the guinea pigs were observed 3 to 4 times a day to observe the guinea pig's spirit, appetite, coat gloss, physical condition, alertness, and ability to avoid capture. No changes were seen after 21 days.

Embodiment 2

[0054] After taking basic fuchsin, the phenomenon that basic fuchsin passes through the blood at different times can be seen that basic fuchsin is absorbed into the blood in a dissolved state, and through the process of entering blood cells, it can make the phagocytic cells Bacteria have the opportunity to combine with basic fuchsin, while raising the pH of body fluids. It destroys the weak acidic environment where bacteria grow and kills bacteria. At this time, it can promote the body's powerful immune system to play its full role.

[0055] Blood observation:

[0056] 1. Observation object:

[0057] 1. Healthy subjects shall be observed as normal population.

[0058]2. Among the patients, recovered volunteers were used as experimental subjects.

[0059] 2. Instruments:

[0060] Binocular Biological Microscope XSP-12G

[0061] Manufacturer: Jiangguang Instrument General Factory

[0062] 3. Reagents:

[0063] 1. Wright-Giemsa staining solution (commercially available) ...

Embodiment 3

[0076] Case Description:

[0077] 1. The patients are all diagnosed by regular hospitals, who cannot be cured by long-term treatment and have relapsed repeatedly.

[0078] 2. Patients with liver and kidney damage after traditional treatment cannot continue treatment.

[0079] 3. There are obvious symptoms before taking the medicine.

[0080] 4. After taking the medicine, the liver, kidney and other organs are normal.

[0081] The medicine used by the patient: basic fuchsin (with medical starch added).

[0082] Dosage for patients: capsule 600mg / capsule (wherein basic fuchsin:medical starch=55~65:35~45), 1-2 capsules / day.

[0083] Dosage: Take 1-2 capsules before breakfast or 1 capsule in the morning and evening, depending on the condition. See Table 3 and 4 for details.

[0084] Table 3 Patient Information Form

[0085]

[0086] Table 4 patient medical records

[0087]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention aims to provide a medicine for treating digestive tract inflammation. The medicine comprises basic fuchsin as an active ingredient, and the active ingredient is blended with basic fuchsin pharmaceutically acceptable auxiliary materials or auxiliary components. The medicine can thoroughly treat inflammatory diseases of the digestive tract, is free of toxic or side effects, normal in liver and kidney after being taken orally for two years, convenient in material taking, and cheap in price, and facilitates industrial production.

Description

technical field [0001] The invention belongs to the field of medicine, and particularly provides a medicine for treating digestive tract inflammation. Its active ingredient is basic fuchsin, and the medicine is synthesized with a medically acceptable auxiliary material—medical starch, which can completely cure esophagitis, gastritis, Inflammation of the digestive tract such as gastric ulcer and gastric erosion. Background technique [0002] The energy source of the human body is to maintain the continuation of life by ingesting food, digesting and absorbing it through the digestive tract to supply the body with energy. So digestion is one of the important physiological functions of the human body. Through a series of digestive processes, various nutrients in food, including carbohydrates, proteins, fats, vitamins, inorganic salts and some trace elements, are transformed into simple and easy-to-absorb forms, and then absorbed by the intestinal tract, becoming The substances...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/136A61P1/04A61P1/00A61P29/00
CPCA61K31/136
Inventor 曹加成曹力源胡淑贤
Owner 胡淑贤
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com